FRAZIER MANAGEMENT LLC
SEATTLE, WA · CIK 1032165 · 13F filing filed 2021-11-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityFRAZIER MANAGEMENT, L.L.C. (US)
- Others nearbySeattle, WA
As an employer
US visa salary filings
- Filings FY20251
- Median salary offered$125,000
- Middle half$125,000 – $125,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Associate, Investment AnalystSeattle, WA | 1 | $125,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.
$1.2bn
reported value
+15.3% vs Q2 2021
41positions
67.1%in top 10
8 new
10 added
5 reduced
1 sold out
vs Q2 2021
Holdings, Q3 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $201.5m16.12% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $187.1m14.97% | Unchanged |
| MIRUM PHARMACEUTICALS INC MIRM | $71.1m5.69% | Unchanged |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $65.9m5.28% | Added +536.3k |
| IMAGO BIOSCIENCES INC COM | $59.5m4.76% | New |
| VAXCYTE INC PCVX | $58.6m4.69% | Unchanged |
| TRILLIUM THERAPEUTICS INC TR | $55.0m4.40% | Unchanged |
| GRITSTONE BIO INC GRTS | $50.4m4.03% | Added +3.6m |
| PASSAGE BIO INC COM | $49.9m3.99% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $40.3m3.22% | Reduced -16.6k |
| TARSUS PHARMACEUTICALS INC TARS | $30.5m2.44% | Unchanged |
| IVERIC BIO INC OPHT | $29.9m2.39% | Reduced -706.1k |
| SUTRO BIOPHARMA INC COM | $27.7m2.22% | Added +467.2k |
| VIRIDIAN THERAPEUTICS INC VRDN | $24.8m1.98% | New |
| ANAPTYSBIO INC ANAB | $24.4m1.95% | Unchanged |
| AUTOLUS THERAPEUTICS PLC AUTL | $23.1m1.85% | Added +1.2m |
| SYNDAX PHARMACEUTICALS INC SNDX | $22.7m1.82% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $22.0m1.76% | New |
| CHINOOK THERAPEUTICS INC ADRO | $21.3m1.71% | Added +571.9k |
| ALPINE IMMUNE SCIENCES INC NVLS | $18.9m1.51% | Reduced -799.6k |
| BICYCLE THERAPEUTICS PLC BCYC | $18.4m1.47% | New |
| CRINETICS PHARMACEUTICALS IN CRNX | $17.9m1.43% | New |
| SIERRA ONCOLOGY INC COM NEW | $17.6m1.41% | Added +601.9k |
| FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 | $15.1m1.20% | Unchanged |
| REPLIMUNE GROUP INC REPL | $14.6m1.17% | New |
| GRACELL BIOTECHNOLOGIES INC SPONSORED ADS | $11.8m0.95% | New |
| REGENXBIO INC RGNX | $9.9m0.79% | Reduced -116.1k |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $9.3m0.75% | Added +373.7k |
| MOLECULAR TEMPLATES INC COM | $9.2m0.74% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $7.3m0.59% | Added +37.6k |
| SCHOLAR ROCK HLDG CORP SRRK | $5.2m0.41% | Unchanged |
| IMMUNOVANT INC IMVT | $5.1m0.41% | Added +331.8k |
| APTINYX INC COM | $4.4m0.35% | Unchanged |
| EPIZYME INC EPZM | $3.8m0.30% | Unchanged |
| ALLENA PHARMACEUTICALS ALNA | $3.0m0.24% | Unchanged |
| ESSA PHARMA INC EPI | $2.9m0.23% | Added +41.7k |
| KALVISTA PHARMACEUTICALS INC KALV | $2.7m0.22% | New |
| BELLUS HEALTH INC NEW BLU | $2.6m0.21% | Reduced -863.5k |
| GALERA THERAPEUTICS INC COM | $2.0m0.16% | Unchanged |
| FREELINE THERAPEUTICS HLDGS SPONSORED ADS | $1.9m0.15% | Unchanged |
| NABRIVA THERAPEUTICS PLC SHS | $507.0k0.04% | Unchanged |
Sold out since Q2 2021
| Security | Value then |
|---|---|
| TRANSLATE BIO INC | $57.4m2.1m shares |